Pehlivan, U. A. Et Al. 2023. Central nervous system neurotoxicity associated with nelarabine in T-cell acute lymphoblastic leukemia. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.1 , 246-251.

Pehlivan, U. A., GÜRKAN, E., Acar, I. H., & BIÇAKCI, Y. K., (2023). Central nervous system neurotoxicity associated with nelarabine in T-cell acute lymphoblastic leukemia. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.1, 246-251.

Pehlivan, Umur Et Al. "Central nervous system neurotoxicity associated with nelarabine in T-cell acute lymphoblastic leukemia," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.1, 246-251, 2023

Pehlivan, Umur A. Et Al. "Central nervous system neurotoxicity associated with nelarabine in T-cell acute lymphoblastic leukemia." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.1, pp.246-251, 2023

Pehlivan, U. A. Et Al. (2023) . "Central nervous system neurotoxicity associated with nelarabine in T-cell acute lymphoblastic leukemia." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.1, pp.246-251.

@article{article, author={Umur A. Pehlivan Et Al. }, title={Central nervous system neurotoxicity associated with nelarabine in T-cell acute lymphoblastic leukemia}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2023, pages={246-251} }